Elective replacement of peripheral intravenous cannulas in neonates.

BACKGROUND

Newborns admitted to neonatal units often require vascular access. Peripheral intravenous cannulas allow essential medication, fluids, and/or parenteral nutrition to be delivered. Peripheral intravenous cannulas are often associated with complications, such as extravasation, infiltration, phlebitis, leakage, spontaneous dislodgement, and catheter-associated blood stream infection.

METHODS

A secondary analysis of a randomized controlled trial evaluating standard replacement versus elective replacement (72-96 h) of peripheral intravenous cannula was conducted in a tertiary-level neonatal unit in Melbourne, Australia. The main outcome of this analysis was to assess the risk of combined adverse events associated with elective replacement of peripheral intravenous cannula. A cost analysis of the intervention was also conducted.

RESULTS

Combined adverse outcomes noted per infant were 48 (87.27%) in the standard replacement group versus 44 (75.86%) in the elective replacement group (RR 0.87; 95% CI 0.71-1.04, = 0.15). In terms of combined adverse outcome per 1000 intravenous hours, there was a significant risk ratio of 0.81 in the elective group compared with the standard group (95% CI 0.65-0.98, = 0.04). Gestation (adjusted odds ratio (AOR) 0.58; 95% CI 0.35-0.96, = 0.03), male gender (AOR 4.65; 95% CI 1.07-20.28, = 0.04), elective replacement (AOR 0.12; 95% CI 0.03-0.68, = 0.01), and the total number of re-sites (AOR 27.84; 95% CI 4.61-168.18, < 0.001) were significant risk factors associated with adverse events. There were also significantly higher costs involved with elective replacement.

CONCLUSION

Elective replacement of peripheral intravenous cannulas was not shown to reduce the risk of combined adverse events. Elective peripheral intravenous cannula replacement also incurred a higher cost.